BPC-157, a peptide discovered by Predrag Sikiric in Croatia, is touted for its healing properties but lacks extensive human trial data. The debate over its regulation in the U.S. intensifies as some advocate for access to unapproved therapies, while others caution against their use due to insufficient evidence.

• 01BPC-157 was discovered in the 1980s by Predrag Sikiric, who isolated it from gastric juice, believing it could help heal stress-induced damage.
• 02Despite promising animal studies, BPC-157 has not undergone rigorous human clinical trials, raising concerns about its safety and efficacy.
• 03The FDA is considering allowing pharmacies to sell unapproved peptides like BPC-157, highlighting a shift in drug regulation discussions in the U.S.
• 04Sikiric's research lacks some critical details, including the full amino acid sequence of the peptide, leading to skepticism about its natural occurrence in the body.
• 05The peptide has gained popularity in the gray market among bodybuilders and biohackers, despite warnings from medical professionals about the risks of using unapproved substances.

The ongoing debate about BPC-157's approval and regulation could affect access to experimental treatments for patients with chronic conditions.